In conclusion, these data are consistent with the results of the in vitro cell proliferation, migration and invasion assays and indicate that KLK8 is associated with CRC progression and tumorigenesis in vivo, and these phenomena could be reversed by PAR1 inhibition. Here, KLK8 is linked to colorectal carcinoma.